Anemia in myelofibrosis is multifactorial, with contributing factors including elevated hepcidin levels due to inflammation and cytokine release, decreased iron availability for erythropoiesis, and the use of JAK inhibitors. This evidence concerns the gene HAMP and myelofibrosis.